FDA releases guidance for prescription drug 3PL provider facilities’ reporting requirements
New Q&A explains annual reporting obligations for 3PL provider facilities
The FDA clarified annual reporting requisites for 3PL provider facilities that handle prescription drugs. The Q&A format focuses on the most frequently asked questions that commenters had about the previously published draft guidance.
The document, which was released on January ninth, clarifies who, what, when and how 3PL provider facilities should report to the FDA.
What 3PL provider facilities need to know:
Any 3PL